Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Call Transcript
It is time to start. (Operator Instructions) For question and answer, we will have that session after the presentation. IR head, Mr. Okubo, the floor is yours.
[Interpreted] Thank you very much for joining us in this 2019 fiscal year conference call. I appreciate your attendance. I would like to act as the moderator. I am Okubo, Global IR Head.
In today's conference call, I'd like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings.
Page 2 of today's presentation carries important points to be noted. Today's presenters as well as the participants for answering questions. Let me introduce them to you. CEO, President, Christophe Weber; CFO, Costa Saroukos; R&
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |